Avance Biosciences is excited to announce our participation in Advanced Therapies USA 2025, a premier conference bringing together leaders in cell and gene therapy, regenerative medicine, and advanced biologics. This event provides a unique opportunity to explore cutting-edge technologies, share insights, and connect with innovators shaping the future of therapeutics.
At the conference, our team will showcase Avance Biosciences’ CGMP and GLP-compliant testing services, including assay development, validation, and sample testing solutions designed to support advanced therapy development. Attendees will learn how our expertise in cell and gene therapy characterization, immunophenotyping, and molecular testing can accelerate program timelines while ensuring regulatory compliance.
We look forward to engaging with fellow scientists, industry leaders, and partners to discuss the latest trends and challenges in advanced therapies. Stop by our booth to meet our experts and discover how Avance Biosciences can help bring your next-generation therapies closer to patients.
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
